Purchases and Sales Made in Q4 2024 in Summit Therapeutics Inc. (SMMT)
This table provides information about the institutional ownership of Summit Therapeutics Inc. (SMMT) during Q4 2024. The information is specifically focused on institutions that hold shares of Summit Therapeutics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 12, 2025
Q4 2024
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-8.36K- 8.72% |
$146K - $196K
|
87.5K
$1.68M
|
|
|
Feb 14, 2025
Q4 2024
|
Options Solutions, LLC
Chevy Chase, MD |
SELL
|
- |
-10.9K- 41.63% |
$192K - $257K
|
15.3K
$295K
|
|
|
Feb 13, 2025
Q4 2024
|
Bank Of Montreal
Toronto, A6 |
SELL
|
- |
-13.4K- 13.68% |
$234K - $313K
|
84.2K
$1.62M
|
|
|
Feb 03, 2025
Q4 2024
|
Allianz Asset Management Gmb H
Munich, 2M |
SELL
|
- |
-13.9K- 23.73% |
$244K - $327K
|
44.8K
$862K
|
|
|
Feb 11, 2025
Q4 2024
|
Virtu Financial LLC
New York, NY |
SELL
|
- |
-15.4K- 36.37% |
$269K - $360K
|
26.9K
$517K
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-16.3K- 2.82% |
$286K - $383K
|
561K
$10.8M
|
|
|
Jan 17, 2025
Q4 2024
|
Sg Americas Securities, LLC
|
SELL
|
- |
-19.6K- 59.8% |
$343K - $460K
|
13.2K
$254K
|
|
|
Feb 13, 2025
Q4 2024
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-20.8K- 23.08% |
$364K - $488K
|
69.3K
$1.33M
|
|
|
Jan 24, 2025
Q4 2024
|
Calamos Advisors LLC
|
SELL
|
- |
-22.9K- 49.04% |
$402K - $538K
|
23.8K
$459K
|
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-23.1K- 14.18% |
$404K - $541K
|
140K
$2.69M
|
|
|
Feb 14, 2025
Q4 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-35.3K- 13.1% |
$619K - $829K
|
234K
$4.51M
|
|
|
Feb 14, 2025
Q4 2024
|
Wolverine Trading, LLC
Chicago, IL |
SELL
|
- |
-37.9K- 53.57% |
$664K - $889K
|
32.8K
$632K
|
|
|
Feb 14, 2025
Q4 2024
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-43.9K- 10.19% |
$770K - $1.03M
|
387K
$7.45M
|
|
|
Feb 03, 2025
Q4 2024
|
Handelsbanken Fonder Ab
|
SELL
|
- |
-50.9K- 57.84% |
$892K - $1.19M
|
37.1K
$714K
|
|
|
Feb 14, 2025
Q4 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-106K- 96.54% |
$1.86M - $2.49M
|
3.8K
$73.1K
|
|
|
Feb 14, 2025
Q4 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-216K- 61.53% |
$3.79M - $5.07M
|
135K
$2.6M
|
|
|
Feb 14, 2025
Q4 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-289K- 78.92% |
$5.07M - $6.78M
|
77.2K
$1.49M
|
|
|
Feb 14, 2025
Q4 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-366K- 91.04% |
$6.41M - $8.59M
|
36K
$693K
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-463K- 71.21% |
$8.12M - $10.9M
|
187K
$3.61M
|